Stock research
HELP Cybin Inc. Common Stock
Healthcare • Biotechnology
Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline...…
Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.
1Y change
+34.60%
Range high
$8.71
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in HELP?
Price
Showing 1Y history. Source: FMP historical price full.
- Prev Close
- $7.82
- Day High
- $7.96
- Day Low
- $7.51
- 52w High
- $9.12
- 52w Low
- $3.76
- Volume
- 478,427
- Avg Volume
- Beta
- 0.622
* TTM/most recent where available
Company
- Ticker
- HELP
- Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- CA
- CEO
- Eric So
- Employees
- 100
- Website
- www.helus.com
Key Metrics
- Market Cap
- 493M
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).